SMAD5 antibody
Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
SMAD5 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab07998
tested applications
ELISA, IF, WB, FC, IP
Description
Transcriptional modulator activated by BMP(bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD(R-SMAD).
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | SMAD family member 5 (SMAD5) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | WB: 1:500-1:2000; IP: 1:200-1:2000; IF: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | 52 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, IF, WB, FC, IP |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | Q99717 |
| Gene ID | 4090 |
| Alias | Mothers against decapentaplegic homolog 5 (MAD homolog 5, Mothers against DPP homolog 5),JV5-1,SMAD family member 5 (SMAD 5, Smad5, hSmad5),SMAD5,MADH5 |
| Background | Antibody anti-SMAD5 |
| Status | RUO |
| Note | Mol. Weight 52 kDa |
Descripción
Related Products
SMAD5 antibody
Transcriptional modulator activated by BMP(bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD(R-SMAD).
Ver Producto
Recombinant Human SMAD5
Ver Producto
Mothers Against Decapentaplegic Homolog 5 (SMAD5) Antibody
SMAD5 Antibody is a Rabbit Polyclonal antibody against SMAD5. The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants.
Ver Producto